MedPath

The effect of extra-epineural administered dexmedetomidine: a volunteer study

Phase 1
Conditions
healthy volunteers
Registration Number
DRKS00003529
Lead Sponsor
Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
36
Inclusion Criteria

Healthy male volunteers aged between 18 and 45 years
-BMI < 30 kg/m2
-Written informed consent given by volunteers after being provided with detailed information about the nature, risks, and scope of the clinical study as well as the expected desirable and adverse effects of the drug
-No legal incapacity and/or other circumstances rendering the volunteer unable to understand the nature, scope and possible consequences of the study

Exclusion Criteria

Anatomical abnormalities of the forearm identified by physical examination, use of NSAID during the last 2 weeks, known allergy or hypersensitivity against ropivacaine or other amino-amide local anaesthetics and dexmedetomidine, participation in another clinical study within the last 4 weeks prior to study, coagulopathy, abnormalities in ECG that are considered clinically relevant like AV-block or bradycardia, hypotony, unreliability and/or lack of cooperation and mobility, other objections to participate in the study in the opinion of the investigator

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Investigation of the prolongation of sensory and motor blockade of the ulnar nerve by dexmedetomidine added to ropivacaine. <br>Sensory and motor block will be evaluated as follows:<br>Prior the block, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 30 min, 60 min, after the block and then every 30 min until complete recovery.<br>Evaluation of sensory scores:<br>A pinprick test in comparison with the contralateral area propria of the ulnar nerve will be performed (0% = no difference to the contra lateral side; 100% = complete sensory loss). <br>Evaluation of motor scores:<br>-3 = no difference, adduction against contra-force possible<br>-2 = slight difference, adduction against slight contra-force hardly possible<br>-1 = significant difference, adduction without contra-force hardly possible<br>-0 = no active adduction possible, paralysis<br>The tests will be performed until complete recovery. Results will be documented.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome parameter is the site of action (systemic versus local). Test timepoints are the same because it is a blind study.
© Copyright 2025. All Rights Reserved by MedPath